Related Experiment Video

Updated: Jul 17, 2026

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
07:32

Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

Published on: May 6, 2020

How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug?

Eric P Vignon1, Larry Moreland

  • 1Claude Bernard University Lyon, Service de Rhumatologie, Centre Hospitalier Lyon-Sud,165 chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France. eric.vignon@chu-lyon.fr

Osteoarthritis and Cartilage
|December 31, 2003
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness08:52

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...